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Scientific Opinion on Flavouring Group Evaluation 99 
Revision 1 (FGE.99Rev1): Consideration of furanone 
derivatives evaluated by the JECFA  
(63rd, 65th and 69th meetings) 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings 
and Processing Aids (CEF) 
Abstract 
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) of the 
European Food Safety Authority was requested to consider evaluations of flavouring substances 
assessed since 2000 by the Joint FAO/WHO Expert Committee on Food Additives (the JECFA), and to 
decide whether further evaluation is necessary, as laid down in Commission Regulation (EC) No 
1565/2000. The substances were evaluated through a stepwise approach that integrates information 
on structure-activity relationships, intake from current uses, toxicological threshold of concern, and 
available data on metabolism and toxicity. The present consideration concerns a group of six furanone 
derivatives evaluated by the JECFA at their 63rd, 65th and 69th meetings. This revision of FGE.99 
includes the assessment of the 2,5-dimethyl-4-methoxyfuran-3(2H)-one [FL-no: 13.089] cleared for 
genotoxicity concern compared to the previous version. The Panel concluded that none of the six 
substances gives rise to safety concerns at the levels of dietary intake, estimated on the basis of the 
MSDI approach [FL-nos: 13.010, 13.084, 13.085, 13.089, 13.099 and 13.176]. The specifications of 
the materials of commerce have also been considered and are adequate for all candidate substances 
in this FGE. However, for all substances use levels are required to calculate the mTAMDIs in order to 
identify those flavouring substances that need more refined exposure assessment and to finalise the 
evaluation. 
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Summary 
Following a request from the European Commission, the EFSA Panel on Food Contact Materials, 
Enzymes, Flavourings and Processing Aids (CEF Panel) was asked to deliver a scientific opinion on the 
implications for human health of chemically defined flavouring substances used in or on foodstuffs in 
the Member States. In particular, the Panel was requested to consider the Joint FAO/WHO Expert 
Committee on Food Additives (the JECFA) evaluations of flavouring substances assessed since 2000, 
and to decide whether no further evaluation is necessary, as laid down in Commission Regulation (EC) 
No 1565/2000. These flavouring substances are listed in the Register, which was adopted by 
Commission Decision 1999/217/EC and its consecutive amendments. 
The present revision of FGE.99, FGE.99Rev1, includes the assessment of one additional candidate 
substance, the 2,5-dimethyl-4-methoxyfuran-3(2H)-one [FL-no: 13.089], which was evaluated by the 
JECFA at its 63rd meeting. This substance, containing an α,β-unsaturated carbonyl, raised concern for 
genotoxicity. In the recently published FGE.220Rev3, new genotoxicity data on the structurally related 
4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] have become available. The Panel concluded 
that the data available rules out the concern for genotoxicity for [FL-no: 13.089] and accordingly this 
substance can be evaluated through the Procedure in this revision. 
This consideration deals with six flavouring substances [FL-nos: 13.010, 13.084, 13.085, 13.089, 
13.099 and 13.176], which belong to a group of 18 tetrahydrofuran and furanone derivatives and a 
group of 40 furan-substituted aliphatic hydrocarbons, alcohols, aldehydes, ketones, carboxylic acids 
and related esters, sulphides, disulphides and ethers evaluated by the JECFA at the 63rd, 65th and 
69th meetings.  
The Panel agrees with the application of the Procedure as performed by the JECFA for only one 
substance [FL-no: 13.010] considered in this FGE. The JECFA stated that the four substances [FL-nos: 
13.084, 13.085, 13.089 and 13.099] belong to structural class II, but as data on natural occurrence 
indicate that these substances cannot be considered to be common components of food, the Panel 
disagrees with this and allocates these four substances to structural class III. In addition, for 
substance with [FL-no: 13.176] the JECFA concluded that the Procedure for the Safety Evaluation of 
Flavouring Agents could not apply because of the unresolved toxicological concerns related to the 
epoxidation and opening of the furan ring. The Panel disagreed with the conclusions by the JECFA and 
regarded this substance to be sufficiently structurally related to the other substances in this group. 
The Panel concluded that there is no safety concern for the six substances [FL-nos: 13.010, 13.084, 
13.085, 13.089, 13.099 and 13.176] in this FGE, based on the MSDI approach. 
In order to determine whether the conclusion for the six JECFA evaluated substances can be applied 
to the materials of commerce, it is necessary to consider the available specifications. Adequate 
specifications including complete purity criteria, identity tests and information on stereoisomeric 
composition are available for all JECFA evaluated substances.  
For all six substances evaluated through the Procedure use levels are required to calculate the 
mTAMDIs in order to identify those flavouring substances that need more refined exposure 
assessment and to finalise the evaluation. 
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1. Introduction  
 Background and Terms of Reference as provided by the requestor 1.1.
The use of flavourings is regulated under Regulation (EC) No 1334/2008 of the European Parliament 
and Council of 16 December 20081 on flavourings and certain food ingredients with flavouring 
properties for use in and on foods. On the basis of Article 9(a) of this Regulation, an evaluation and 
approval are required for flavouring substances. 
The Union list of flavourings and source materials was established by Commission Implementing 
Regulation (EC) No 872/2012.2 The list contains flavouring substances for which the scientific 
evaluation should be completed in accordance with Commission Regulation (EC) No 1565/2000.3 
On 25 September 2013, the EFSA Panel on Food Contact Materials, Enzymes, Flavourings and 
Processing Aids adopted an opinion on Flavouring Group Evaluation 220 (FGE.220Rev2): 
Consideration of genotoxicity data on representatives for heterocyclic α,β-unsaturated Aldehydes, 
Ketones and Related Substances with the α,β-conjugation in the Ring or in the side chain. 
On the basis of the data supplied, the Opinion concluded that the concern for genotoxicity could not 
be ruled out for the substances in this subgroup and therefore the Panel requested a repetition of 
micronucleus study in the presence of S9-mix applying the same conditions and possible in addition 
modified conditions, or by a combined in vivo micronucleus study and Comet assay, including analysis 
of the liver. 
The applicant has submitted additional data in response to this EFSA evaluation. 
1.1.1. Terms of Reference as provided by the European Commission 
The European Commission requests the European Food Safety Authority (EFSA) to evaluate this new 
information and, depending on the outcome, proceed to the full evaluation on this flavouring 
substance in accordance with Commission Regulation (EC) no 1565/2000. 
 Interpretation of the Terms of Reference 1.2.
The present scientific opinion FGE.99Rev1 covers the safety assessment of the following flavouring 
substance: 2,5-dimethyl-4-methoxyfuran-3(2H)-one [FL-no: 13.089]. 
  
                                                          
1 Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16 December 2008 on flavourings and certain 
food ingredients with flavouring properties for use in and on foods and amending Council Regulation (EEC) No 1601/91, 
Regulations (EC) No 2232/96 and (EC) No 110/2008 and Directive 2000/13/EC. OJ L 354, 31.12.2008, p. 34-50. 
2 Commission implementing Regulation (EU) No 872/2012 of 1 October 2012 adopting the list of flavouring substances provided 
for by Regulation (EC) No 2232/96 of the European Parliament and of the Council, introducing it in Annex I to Regulation (EC) 
No 1334/2008 of the European Parliament and of the Council and repealing Commission Regulation (EC) No 1565/2000 and 
Commission Decision 1999/217/EC. OJ L 267, 2.10.2012, p, 1-161. 
3 Commission Regulation No 1565/2000 of 18 July 2000 laying down the measures necessary for the adoption of an evaluation 
programme in application of Regulation (EC) No 2232/96. OJ L 180, 19.7.2000, p. 8-16. 
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2. Data and Methodologies  
  Description of key aspects of the evaluation methodology 2.1.
The approach used by EFSA for safety evaluation of flavouring substances is referred to in 
Commission Regulation (EC) No 1565/2000, hereafter named the “EFSA Procedure”. This Procedure is 
based on the Opinion of the Scientific Committee on Food (SCF, 1999), which has been derived from 
the evaluation Procedure developed by the Joint FAO/WHO Expert Committee on Food Additives 
(JECFA, 1995; JECFA, 1996; JECFA, 1997; JECFA, 1999), hereafter named the “JECFA Procedure”. The 
Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF Panel) compares the 
JECFA evaluation of structurally related substances with the result of a corresponding EFSA 
evaluation, focussing on specifications, intake estimations and toxicity data, especially genotoxicity 
data. The evaluations by EFSA will conclude whether the flavouring substances are of no safety 
concern at their estimated levels of intake, whether additional data are required or whether certain 
substances should not be put through the EFSA Procedure. 
The following issues are of special importance. 
2.1.1. Intake 
In its evaluation, the Panel as a default uses the “Maximised Survey-derived Daily Intake” (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe.  
In its evaluation, the JECFA includes intake estimates based on the MSDI approach derived from both 
European and USA production figures. The highest of the two MSDI figures is used in the evaluation 
by the JECFA. It is noted that in several cases, only the MSDI figures from the USA were available, 
meaning that certain flavouring substances have been evaluated by the JECFA only on the basis of 
these figures. For Register substances for which this is the case the CEF Panel will need EU production 
figures in order to finalise the evaluation. 
When the CEF Panel examined the information provided by the European Flavour Industry on the use 
levels in various foods, it appeared obvious that the MSDI approach in a number of cases would 
grossly underestimate the intake by regular consumers of products flavoured at the use level reported 
by the Industry, especially in those cases where the annual production values were reported to be 
small. In consequence, the CEF Panel had reservations about the data on use and use levels provided 
and the intake estimates obtained by the MSDI approach. It is noted that the JECFA at its 65th 
meeting considered ‘how to improve the identification and assessment of flavouring agents for which 
the MSDI estimates may be substantially lower than the dietary exposures that would be estimated 
from the anticipated average use levels in foods’ (JECFA, 2006c). 
In the absence of more accurate information that would enable the CEF Panel to make a more 
realistic estimate of the intakes of the flavouring substances, the Panel has decided also to perform an 
estimate of the daily intakes per person using a ‘modified Theoretical Added Maximum Daily Intake’ 
(mTAMDI) approach based on the normal use levels reported by Industry. 
As information on use levels for the flavouring substances has not been requested by the JECFA or 
has not otherwise been provided to the CEF Panel, it is not possible to estimate the daily intakes using 
the mTAMDI approach for the substances evaluated by the JECFA. The Panel will need information on 
use levels in order to finalise the evaluation. 
2.1.2. Threshold of 1.5 microgram/person per day (step B5) used by the JECFA 
The JECFA uses the threshold of concern of 1.5 μg/person per day as part of the evaluation 
procedure: 
‘The Committee noted that this value was based on a risk analysis of known carcinogens which 
involved several conservative assumptions. The use of this value was supported by additional 
information on developmental toxicity, neurotoxicity and immunotoxicity. In the judgement of the 
Committee, flavouring substances for which insufficient data are available for them to be evaluated 
using earlier steps in the Procedure, but for which the intake would not exceed 1.5 μg/person per day 
would not be expected to present a safety concern. The Committee recommended that the Procedure 
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for the Safety Evaluation of Flavouring Agents used at the forty-sixth meeting be amended to include 
the last step on the right-hand side of the original procedure (“Do the condition of use result in an 
intake greater than 1.5 μg/person per day?”)’ (JECFA, 1999).  
In line with the Opinion expressed by the Scientific Committee on Food (SCF, 1999), the Panel does 
not make use of this threshold of 1.5 μg/person per day. 
2.1.3. Genotoxicity 
As reflected in the Opinion of SCF (SCF, 1999), the Panel has in its evaluation focussed on a possible 
genotoxic potential of the flavouring substances or of structurally related substances. Generally, 
substances for which the Panel has concluded that there is an indication of genotoxic potential in 
vitro, will not be evaluated using the EFSA Procedure until further genotoxicity data are provided. 
Substances for which a genotoxic potential in vivo has been concluded, will not be evaluated through 
the Procedure. 
2.1.4. Specifications 
Regarding specifications, the evaluation by the CEF Panel could lead to a different opinion than that of 
JECFA, since the Panel requests information on e.g. isomerism. 
2.1.5. Structural relationship  
In the consideration of the JECFA evaluated substances, the CEF Panel will examine the structural 
relationship and metabolism features of the substances within the flavouring group and compare this 
with the corresponding FGE. 
 History of the evaluation of the substances in the present FGE 2.2.
The five furanone derivatives [FL-nos: 13.010, 13.084, 13.085, 13.099 and 13.176] considered in 
FGE.99 (EFSA CEF Panel, 2012) were originally members of a group of 58 substances evaluated by 
the JECFA at their 63rd, 65th and 69th meetings (JECFA, 2005b; JECFA, 2006b; JECFA, 2009b) and 
discussed by EFSA in FGE.75 (EFSA, 2008). The Panel concluded that these five substances are 
structurally different to the other substances in FGE.75 and therefore these five substances will be 
considered in a separate FGE (FGE.99). As the five candidate substances are α,β-unsaturated ketones 
they have been considered together with other α,β-unsaturated substances with respect to 
genotoxicity in FGE.220Rev1 (EFSA CEF Panel, 2011). The Panel concluded that the data available 
ruled out the concern for genotoxicity and thus concluded that these five substances can be evaluated 
through the Procedure. 
 
FGE Opinion adopted 
by EFSA 
Link No. of 
candidate 
substances 
FGE.99 27 September 2012 http://www.efsa.europa.eu/en/efsajournal/doc/2901.pdf 5 
FGE.99Rev1 28 October 2015 http://www.efsa.europa.eu/en/efsajournal/doc/4286.pdf 6 
 
The present revision of FGE.99 (FGE.99Rev1) includes the consideration of one additional substance 
2,5-dimethyl-4-methoxyfuran-3(2H)-one [FL-no: 13.089]. 
The substance has been considered with respect to genotoxicity in FGE 220rev3 (EFSA CEF Panel, 
2015) and the Panel concluded that the data available did rule out the concern for genotoxicity and 
accordingly the substance can be evaluated through the Procedure.  
A search in open literature for the new substances did not provide any further data on toxicity or 
metabolism. 
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 Presentation of the substances in the JECFA flavouring group 2.3.
2.3.1. Description 
Status 
The JECFA has at the 63rd meeting evaluated a group of 18 flavouring substances consisting of 
tetrahydrofuran and furanone derivatives (JECFA, 2005b). 
The JECFA has at the 65th meeting evaluated a group of 40 furan-substituted aliphatic hydrocarbons, 
alcohols, aldehydes, ketones, carboxylic acids and related esters, sulphides, disulphides and ethers 
(JECFA, 2006b) where a request for additional data was expressed. The furan group was on the 
agenda again at the 69th JECFA meeting (JECFA, 2009b) where additional data had been provided. 
EFSA Considerations 
This FGE only deals with six of the above mentioned 58 substances, five substances evaluated by the 
JECFA at the 63rd meeting [FL-nos: 13.010, 13.084, 13.085, 13.089, 13.099] and one substance 
evaluated by the JECFA at the 65th meeting [FL-no: 13.176]. They are all furanone derivatives and 
the Panel concluded that these substances should be considered in a separate group. 
2.3.2. Isomers 
Status 
Five substances in the present group of furanone derivatives have one chiral centre. 
EFSA Considerations 
Adequate information on isomeric composition is available for all the candidate substances. 
2.3.3. Specifications 
Status 
The JECFA specifications are available for all substances (JECFA, 2005a; JECFA, 2005c) (see Table 1). 
EFSA Considerations 
The available specifications and information on stereoisomeric composition are considered adequate 
for all candidate substances (see section 2.3.3 and Table 1). 
2.3.4. Intake estimations 
Status 
For all substances evaluated through the JECFA Procedure, intake data are available for the EU. 
EFSA Considerations 
Tonnage data are available for the EU allowing calculation of the intake estimates (MSDI). The Panel 
noted that since no use levels were submitted, mTAMDI values cannot be calculated. 
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Table 1:  Summary of specification data for substances evaluated by the JECFA (JECFA, 2005a; 2005c) 
FL-no 
JECFA-
no 
EU Register 
name 
Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility (a) 
Solubility in 
ethanol (b) 
Boiling point, °C (c) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index (d) 
Spec.gravity 
(e) 
EFSA comments 
13.010 
1446 
4-Hydroxy-2,5-
dimethylfuran-
3(2H)-one 
 
3174 
536 
3658-77-3 
Solid 
C6H8O3 
128.13 
Insoluble 
Soluble 
n.a. 
78-80 
IR NMR MS 
98 % 
n.a. 
 
n.a. 
 
Racemate  
(EFFA, 2012) 
13.084 
1449 
2-Ethyl-4-hydroxy-
5-methyl-3(2H)-
furanone 
 
3623 
 
27538-09-6 
Liquid 
C7H10O3 
142.15 
Soluble 
Soluble 
103 (20 hPa) 
 
IR NMR 
96 % 
1.509-1.514 
 
1.133-1.143 
 
Racemate  
(EFFA, 2012) 
13.085 
1450 
4-Hydroxy-5-
methylfuran-
3(2H)-one 
 
3635 
11785 
19322-27-1 
Solid 
C5H6O3 
114.10 
Soluble 
Soluble 
n.a. 
126-133 
NMR 
97 % 
n.a. 
 
n.a. 
 
 
13.089 
1451 
2,5-Dimethyl-4-
methoxyfuran-
3(2H)-one 
 
3664 
 
4077-47-8 
Liquid 
C7H10O3 
142.15 
Insoluble 
Soluble 
61-63 (0.4 hPa) 
 
NMR 
97 % 
1.475-1.481 
 
1.091-1.097 
 
Racemate  
(EFFA, 2015) 
13.099 
1456 
4-Acetoxy-2,5-
dimethylfuran-
3(2H)-one 
 
3797 
 
4166-20-5 
Liquid 
C8H10O4 
170.17 
Slightly soluble 
Soluble 
243 
 
IR NMR MS 
95 % 
1.476-1.480 
 
1.159-1.167 
 
Racemate  
(EFFA, 2012) 
13.176 
1519 
Furaneyl butyrate 
 
3970 
 
114099-96-6 
Liquid 
C10H14O4 
198.22 
Insoluble 
Soluble 
287 
 
NMR 
95 % 
1.467-1.473 
 
1.095-1.103 
 
Racemate  
(EFFA, 2012) 
(a): Solubility in water, if not otherwise stated. 
(b): Solubility in 95 % ethanol, if not otherwise stated. 
(c): At 1013.25 hPa, if not otherwise stated. 
(d): At 20°C, if not otherwise stated. 
(e): At 25°C, if not otherwise stated. 
O
OHO
O
OHO
O
OHO
O
O O
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 Genotoxicity data 2.4.
2.4.1. Genotoxicity studies – text taken4 from the JECFA (JECFA, 2006a) 
Genotoxicity data in vitro 
4-Hydroxy-5-methylfuran-3(2H)-one [FL-no: 13.085] (10 - 12,000 µg/plate),5 4-hydroxy-2,5-
dimethylfuran-3(2H)-one [FL-no: 13.010] (10 - 10,000 µg/plate), and 2-ethyl-4-hydroxy-5-methyl-
3(2H)-furanone [FL-no: 13.084] (up to 10,000 µg/plate) induced reverse mutations in standard and 
modified Ames assays. Positive results were obtained for 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-
no: 13.010] in Salmonella typhimurium strains TA100, TA102, TA98 and TA97 at the highest dose 
tested (4000 µg/plate) with or without metabolic activation (Xing et al., 1988). In contrast, (Gilroy et 
al., 1978) and (Hiramoto et al., 1996b) reported positive results for this compound only in S. 
typhimurium strain TA100 when tested at concentrations of ≤ 10,000 µg/plate with or without 
metabolic activation. Similarly, 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone [FL-no: 13.084] and 4-
hydroxy-5-methylfuran-3(2H)-one [FL-no: 13.085] produced positive results in S. typhimurium strain 
TA100 with or without metabolic activation (Hiramoto et al., 1996a; Li et al., 1998). 
The standard Rec assay with Bacillus subtilis H17 (rec+) and M45 (rec-) exposed to 4-hydroxy-2,5-
dimethylfuran-3(2H)-one [FL-no: 13.010] at a concentration of 20, 40, 60, 80 and 120 µg/disc yielded 
a dose-dependent DNA damage response (Xing et al., 1988). 
Genotoxicity data in vivo 
In an assay for genotoxicity in vivo, groups of five ICR mice were given a negative control, or 4-
hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] or 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanon 
[FL-no: 13.084] at a concentration of 1000, 2000 or 3000 mg/kg bw by oral administration. Blood was 
drawn at intervals of 15 min after administration for up to 120 min. For 4-hydroxy-2,5-dimethylfuran-
3(2H)-one, the frequency of micronucleated peripheral reticulocytes was increased at a dose of 2000 
and 3000 mg/kg bw, but not at 1000 mg/kg bw. For 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanon, the 
frequency was increased at all three doses (Hiramoto et al., 1998). Kunming mice injected 
intraperitoneally with 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] at a dose of 0, 186, 232 
or 309 mg/kg bw demonstrated a dose-dependent increase in erythrocyte micronucleus formation in 
the bone marrow, reaching a maximum increase of 2.6-fold (Xing et al., 1988). Also male mice 
injected with 4-hydroxy-2,5-dimethylfuran-3(2H)-one at a dose of 0, 232, 464 or 928 mg/kg bw 
exhibited increases in spermatocyte chromosome aberrations (Xing et al., 1988). In a similar assay in 
male Kunming mice given 4-hydroxy-2,5-dimethylfuran-3(2H)-one at a dose of 200, 400 or 800 mg/kg 
bw by intragastric instillation, a significant increase in sister chromatid exchanges in spermatogonial 
cells compared to controls was reported at all three doses (Tian et al., 1992). Positive results were 
also obtained in an assay for micronucleus formation in male mice given 4-hydroxy-2,5-dimethylfuran-
3(2H)-one at a dose of 200, 400 or 800 mg/kg bw by intraperitoneal injection (Tian et al., 1992). The 
increases observed at each dose did not establish a clear dose–response relationship, although 
increases were significantly higher than for the negative control.  
Groups of five or six male ICR mice were given 4-hydroxy-2,5-dimethylfuran-3(2H)-one at a dose of 0, 
500, 1000 or 1500 mg/kg bw by intraperitoneal injection. Blood samples were drawn at 24, 48 and 72 
hours after injection. The frequency of micronucleated peripheral erythrocytes was significantly 
increased at ≥ 500 mg/kg bw, with the maximum frequency of 1.6 % being obtained at 48 hours 
after dosing (Hiramoto et al., 1996b). 
Groups of five or six male ICR mice were given 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone [FL-no: 
13.084] at a dose of 500, 1000 or 1500 mg/kg bw by intraperitoneal injection and samples of 
peripheral blood were taken at 24, 48 and 72 hours after injection. All the mice in the group given 2-
ethyl-4-hydroxy-5-methyl-3(2H)-furanone at a dose of 1500 mg/kg bw died before 24 hours. The 
frequency of micronucleated peripheral erythrocytes was significantly higher than that in the controls 
                                                          
4 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present FGE 
has been removed. 
5 Maximum concentration tested with [FL-no: 13.085] could not be verified in the publications cited by JECFA (2006a). These 
publications mention a maximum concentration of 5000 µg/plate, which has been mentioned in the tables in this FGE. 
Flavouring Group Evaluation 99, Revision 1 
 
 
 
www.efsa.europa.eu/efsajournal 11 EFSA Journal 2015;13(11):4286 
 
in groups given 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone at a dose of 500 or 1000 mg/kg bw. The 
maximum number of micronucleated peripheral erythrocytes was observed at 48 hours at 1000 mg/kg 
bw group (0.58 %) and at 500 mg/kg bw (approximately 0.3 %). The frequency of micronucleated 
peripheral erythrocytes reported in mice given the positive control substance, mitomycin C, at a dose 
of 1 mg/kg bw, was 3.1 % (Li et al., 1998). 
In summary, positive results were obtained in several assays for genotoxicity in vivo in mice given 4-
hydroxy-2,5-dimethylfuran-3(2H)-one via intraperitoneal injection at doses as low as 196 mg/kg bw 
(Xing et al., 1988). Similarly, positive results were also obtained for 4-hydroxy-2,5-dimethylfuran-
3(2H)-one administered orally; however, there are conflicting data pertaining to the lowest dose at 
which 4-hydroxy-2,5-dimethylfuran-3(2H)-one elicits a positive response: 200 mg/kg bw according to 
(Tian et al., 1992); ≥2000 mg/kg bw according to (Hiramoto et al., 1998). 
Putative mechanism of genotoxicity of furanone derivatives 
Furanones induce DNA damage in vitro by generating free radicals that induce strand scission. In the 
presence of metals (e.g. Fe3+) and dissolved oxygen, the enolic hydroxyl group (OH) of the furanone 
is oxidized by single electron transfer to yield the corresponding carbon-centred radical and a reduced 
metal ion (e.g. Fe2+). The carbon-centred radical can couple to molecular oxygen to produce a peroxyl 
radical that may damage DNA. Alternately, the reduced metal ion can auto-oxidize to form a 
superoxide radical anion. The superoxide radical then dismutates into hydrogen peroxide (H2O2). It is 
well recognized that reduced metals react with H2O2 to form a hydroxyl radical, which is a powerful 
oxidizing agent (see Figure 1). Hydrogen peroxide also oxidizes glutathione leading to decreased 
glutathione S-transferase/oxidised glutathione and an increase in cellular oxidative stress. 
 
 
Figure 1:  Mechanism of oxidation of furanone derivatives in vitro. 
In the case of 4-hydroxy-2,5-dimethylfuran-3(2H)-one, experimental evidence for this H2O2-producing 
pathway includes the following: 
 Fe3+ or Cu2+ is readily reduced to Fe2+ or Cu+ in the presence of 4-hydroxy-2,5-dimethylfuran-
3(2H)-one; 
 DNA strand-breaking of super coiled plasmid DNA into an open circular form in the presence 
of 4-hydroxy-2,5-dimethylfuran-3(2H)-one is inhibited in the presence of superoxide 
dismutase and catalase, enzymes used to detoxicate superoxide to form oxygen and water; 
 Hydroxyl radical scavengers such as potassium iodine, sodium azide, or ethanol also inhibit 
DNA strand-breaking; 
 Free radical spin-trapping agents (e.g. 5,5-dimethyl-1-pyrroline N-oxide) also inhibit DNA 
strand-breaking; 
 Oxygen radical trapping agents such as 2-mercaptoethanol and cysteine are also inhibitory; 
 Removal of dissolved oxygen by nitrogen purge decreases DNA strand-breaking and H2O2 
formation; 
 Addition of metal chelating agents also inhibits DNA strand-breaking by depleting the metal 
ions required for this process; 
OHHO
Fe+++ O2
OO
Fe++ O2
-.
O2
-.
superoxide
dismutase
H2O2 OH
hydroxy radical,
DNA strand breaking
Figure 2. Mechanism of oxidation of furanone derivatives in vitro
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 DNA strand-breaking by 4-hydroxy-2,5-dimethylfuran-3(2H)-one was much faster in the 
presence of Fe3+ than in its absence; and 
 Electron spin resonance of a solution of 4-hydroxy-2,5-dimethylfuran-3(2H)-one and 5,5-
dimethyl-1-pyrroline N-oxide showed the presence of hydroxyl radicals and bicarbonate 
radicals (Hiramoto et al., 1996a; Hiramoto et al., 1996b; Yamashita et al., 1998). 
On the basis of these observations, cellular oxidative stress is related to the dose-dependent oxidation 
of 4-hydroxy-2,5-dimethylfuran-3(2H)-one and structurally related furanones, yielding H2O2 and 
eventually hydroxyl radicals (Hiramoto et al., 1996a; Hiramoto et al., 1996b; Li et al., 1998; Yamashita 
et al., 1998).  
The ability of 4-hydroxy-2,5-dimethylfuran-3(2H)-one to induce oxygen radical formation and DNA 
strand breaks is reminiscent of similar activities observed for vitamin C. Vitamin C (ascorbic acid) 
contains an enediol that is superficially related to the enol of 4-hydroxy-2,5-dimethylfuran-3(2H)-one. 
Being both an enol ether and an αβ-unsaturated ketone, 4-hydroxy-2,5-dimethylfuran-3(2H)-one is 
subject to hydrolytic ring opening, to yield an enediol. Like 4-hydroxy-2,5-dimethylfuran-3(2H)-one, 
vitamin C also reduces metal ions and produces superoxide anions to generate hydroxyl radicals that 
cleave DNA. As anticipated, vitamin C exhibits genotoxicity in test systems similar to those in which 
furanones give positive results. In standard Ames assays, ascorbic acid (vitamin C) induces reverse 
mutations in S. typhimurium strains TA104, TA102, TA100 and TA98 at concentrations of 352 - 
1761µg/plate (Ichinotsubo et al., 1981; D’Agostini et al., 2000). In the E. coli Mutoxitest, positive 
results were obtained when ascorbic acid at a concentration of 200, 300 or 400 µg/plate in the 
presence of Cu2+ was incubated with E. coli strain IC203 (Martinez et al., 2000). E. coli IC203 carries 
an oxyR mutation that effectively removes its ability to turn on the biosynthesis of H2O2-protective 
proteins and makes the strain sensitive to DNA damage under conditions of oxidative stress (Blanco et 
al., 1998). 
Increased frequencies of micronucleus formation were observed when ascorbic acid (400, 500 or 600 
µg/ml) was incubated with Chinese hamster cells (Miller et al., 1995). An increase in sister chromatid 
exchanges was observed in Chinese hamster ovary cells in the presence of ascorbic acid at 500 µg/ml 
without metabolic activation (Tennant et al., 1987). In a standard assay for micronucleus formation in 
mice, ascorbic acid at a dose of 1500 mg/kg bw induced a significant increase (Shelby et al., 1993). 
Conclusion 
Furanones are a class of substances present naturally in food and are also added as flavouring agents. 
The principal furanone used as a flavouring agent is 4-hydroxy-2,5-dimethylfuran-3(2H)-one. In 
humans, 4-hydroxy-2,5-dimethylfuran-3(2H)-one is rapidly absorbed in the gastrointestinal tract and 
conjugated with glucuronic acid in the liver. Free 4-hydroxy-2,5-dimethylfuran-3(2H)-one is not 
detected in the blood of human volunteers to whom it is administered as a constituent of 
strawberries; its glucuronic acid conjugate is the principal urinary metabolite (Roscher et al., 1997). 
Thus, the potential for chemical reaction of 4-hydroxy-2,5-dimethylfuran-3(2H)-one with important 
cellular macromolecules, especially DNA, appears to be low.  
Genotoxicity with 3-(2H)-furanone derivatives, notably 4-hydroxy-2,5-dimethylfuran-3(2H)-one and 2-
ethyl-4-hydroxy-5-methyl-3-(2H)-furanone, was observed in standardized bacterial (Gilroy et al., 
1978; Xing et al., 1988; Hiramoto et al., 1996a; Hiramoto et al., 1996b; Li et al., 1998) and 
mammalian assays (Xing et al., 1988; Tian et al., 1992; Hiramoto et al., 1996b). A mechanism for 
genotoxicity involving dose-dependent formation of H2O2 and oxidized furanones has been extensively 
studied (Hiramoto et al., 1995; Hiramoto et al., 1996a; Hiramoto et al., 1996b); these studies indicate 
that, at high doses, DNA single-strand breaks result from the reaction of hydroxyl radicals with DNA.  
Despite the fact that 4-hydroxy-2,5-dimethylfuran-3(2H)-one causes genotoxicity, it is not 
carcinogenic in rats. Two studies, one with 4-hydroxy-2,5-dimethylfuran-3(2H)-one and the other with 
a structurally related furanone, showed no evidence of carcinogenicity at intakes that are orders of 
magnitude greater than the intake of furanones added as flavouring agents (Munday and Kirkby, 
1973; Kelly and Bolte, 2003). Furthermore, vitamin C, a structurally similar compound with a 
genotoxicity test profile similar to that of 4-hydroxy-2,5-dimethylfuran-3(2H)-one, does not 
demonstrate carcinogenicity (NRC, 1996). In a 2-year bioassay, the NOEL for 4-hydroxy-2,5-
dimethylfuran-3(2H)-one was 200 mg/kg bw per day in rodents. This intake is approximately 2000 
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times higher than the daily per capita intake (‘eaters only’) of 0.088 mg/kg bw per day from use of  
4-hydroxy-2,5-dimethylfuran-3(2H)-one as a flavouring agent. 
After consideration of all the available data, the Committee concluded that it is highly unlikely that  
4-hydroxy-2,5-dimethylfuran-3(2H)-one, other furanones or tetrahydrofurans, would pose any 
significant genotoxic risk to humans under the conditions of use as flavouring agents. Similarly,  
2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone was considered not to pose a genotoxic risk. 
EFSA conclusion on the genotoxicity assessment by the JECFA 
The Panel notes the mechanism identified by the JECFA and agrees that the positive results obtained 
in genotoxicity studies for these studies are likely to be due to the formation of reactive oxygen 
species. However, the Panel concluded that the possibility of genotoxicity in germ cells had not been 
excluded and in FGE 220 (EFSA, 2009) the Panel requested further studies from Industry on germ cell 
genotoxicity. Further studies were submitted by Industry and reviewed by the panel in FGE 220Rev1 
(EFSA CEF Panel, 2011). The Panel’s conclusions on these studies can be found in Section 2.4.2. 
For a summary of in vitro / in vivo genotoxicity data considered by the JECFA, see Tables 2 and 3. 
There is no relevant text on genotoxicity from the 65th and 69th meetings on the substances in 
question. 
2.4.2. Genotoxicity studies and conclusion on genotoxicity and carcinogenicity - 
text taken6 from FGE.220Rev1 (EFSA CEF Panel, 2011). 
The following text is relevant for five substances [FL-nos: 13.010, 13.084, 13.085, 13.099 and 13.176] 
in this FGE. 
For three substances the following results have been reported: 
4-Hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] 
For 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] publications on in vitro and in vivo 
studies are available. In three studies the potential of the test substance to induce gene mutations in 
S. Typhimurium was studied. The substance was found positive in two valid studies and in one study 
with limited validity. The substance did not cause gene mutations in a valid study in Escherichia coli 
WP2 uvrA-. It was also observed that the substance caused DNA repair in a less relevant bacterial test 
and single strand breaks in purified DNA. 
All in vivo studies provided indications for a genotoxic potential. Two studies showing micronucleus 
formation in peripheral blood cells were considered valid (Hiramoto et al., 1996b; Hiramoto et al., 
1998); in a third study similar evidence but of limited validity was obtained (Xing et al., 1988). The 
latter authors also reported an increase in sister chromatid exchanges (SCE) in mouse bone marrow, 
but the validity of that observation could not be assessed. In addition this endpoint is of questionable 
relevance for the assessment of genotoxicity. 
In addition to the genotoxicity observed in somatic cells, three studies provided evidence for 
genotoxicity in germ cells.  
The evidence of chromosome aberration induction in mouse germ cells provided in the study by Xing 
et al. (1988) is poor because it is essentially based on an increase of premature disjunction of sex 
chromosomes and autosomes at metaphase I. This effect could be considered at most an alert of 
possible subsequent missegregation events; even so, data have been published (Liang and 
Pacchierotti, 1988) showing the lack of correlation between univalents at metaphase I and aneuploidy 
at metaphase II.  
Tian et al. (1992) reported an induction of SCE in spermatogonia. Incomplete information is given on 
the experimental protocol. There is a dose-dependent increase of SCE/cell, with each dose group 
significantly higher than the negative control. For these reasons, these data seem to be convincing 
although obtained on a small (3) number of animals/group. The relevance of SCE in spermatogonia as 
an indicator of heritable genetic damage is limited. 
                                                          
6 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present FGE 
has been removed. In addition, minor editorial changes were included to maintain the logic of the text. 
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In the same paper Tian et al. (Tian et al., 1992) reported the induction of micronuclei in early sperm 
cells. This test measures the induction of DNA lesions in preleptotene spermatocytes that can lead to 
breaks and fragments several days later, at the first or second meiotic division. The test has not been 
standardised and validated for routine regulatory application, but has been conducted by more than 
one laboratory in the world with consistent results. The study seems adequately performed. Staining 
with Giemsa is not optimal and does not allow distinguishing among phases of spermatid 
differentiation as recommended by the guidelines (Russo, 2000). However, this drawback could hardly 
produce an overestimation of the effect, more likely, if any, an underestimation. 
4-Hydroxy-5-methylfuran-3(2H)-one [FL-no: 13.085] and 2-Ethyl-4-hydroxy-5-methyl-3(2H)-furanone 
[FL-no: 13.084] 
Reverse mutations were also observed in S. typhimurium TA100, but not TA98 with 4-hydroxy-5-
methylfuran-3(2H)-one [FL-no: 13.085] and with 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone [FL-no: 
13.084]. The other strains were not tested. The same substances could induce single strand breaks in 
purified DNA. With 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone [FL-no: 13.084] also induction of 
micronuclei in peripheral erythrocytes was observed in two valid in vivo assays. 
Mechanistic data 
Mechanistic studies were carried out with [FL-nos: 13.010, 13.084 and 13.085], all of which were 
considered valid. These substances were identified as Maillard reaction products in soy sauce. When 
the substance [FL-no: 13.085] was incubated with super coiled pBR 322 plasmid DNA, single strand 
breaks were observed at pH 4.4, but not at pH 7.4. When a spin trap was also present, formation of 
hydroxy radicals together with a carbon-centred radical could be demonstrated. Subsequent addition 
of superoxide dismutase and catalase inhibited the DNA breaking showing involvement of hydrogen 
peroxide. Potassium iodide, mannitol, sodium azide, and ethanol were also inhibitory to the DNA 
breaking showing involvement of hydroxy radicals. Spin trapping agents and thiol compounds and 
metal chelators also effectively inhibited the breaking of DNA (Hiramoto et al., 1996a). Similar studies 
were carried out with [FL-nos: 13.010 and 13.084] with the same results and it was also 
demonstrated that these substances are capable of reducing Fe3+ at neutral or alkaline pH (Li et al., 
1998).  
For validation and study results see Tables 2 and 3. 
Conclusion on genotoxicity and carcinogenicity - text taken from FGE.220 (EFSA, 2009) 
Apart from the negative predictions for the substances in the DTU-NFI MultiCASE model for the Ames 
test, the (Q)SAR models do not seem to generate a reliable and reproducible pattern of predictions on 
the genotoxicity for the substances in this FGE.  
With several substances [FL-nos: 13.010, 13.084, 13.085, 13.099 and 13.176], indications have been 
obtained in in vitro studies that the genetic damage they cause is related to the generation of reactive 
oxygen species as a result of redox cycling in combination with metal ions present in the media. The 
valid positive in vivo data were obtained with high dose levels that may be anticipated to have 
exhausted the anti-oxidant capacity of the target cells. This, in combination with the absence of 
carcinogenicity observed in a valid carcinogenicity study in rats with one of the substances [FL-no: 
13.010], which was tested positive in the genotoxicity assays, takes away a concern for genotoxic 
events resulting in carcinogenicity in somatic cells. 
For two of the studies in which genotoxic effects were observed in germ cells in vivo the studies had 
limited validity and/or address endpoints that may have limited relevance for the assessment of 
genotoxic potential. The Panel noted that a positive result was obtained in a micronucleus study in 
early sperm cells. However, a micronucleus test does not discriminate between aneuploidy and 
chromosomal breakage. The observed effects in the germ cells could be the result of the 
malsegregation of chromosomes which is generally considered a thresholded event. They may 
alternatively be the result of the (thresholded) generation of reactive oxygen species. 
Conclusion – text taken from FGE.220 (EFSA, 2009) 
For the substances [FL-nos: 13.010, 13.084, 13.085, 13.099 and 13.176], evidence for genotoxicity 
was obtained in vitro and in vivo. Evidence is available from in vitro studies that the genotoxicity of 
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the candidate substances in this subgroup may be caused by indirect (threshold) mechanisms of 
action (in particular generation of reactive oxygen species). The concern for carcinogenicity is 
alleviated, since one of the substances, for which positive genotoxicity data in mice were obtained, 
was not carcinogenic in a valid chronic assay in rats. Therefore, no further genotoxicity tests in 
somatic cells are required. However, some evidence was also available that this substance might elicit 
genotoxic effects in germ cells, which theoretically may result in reduced reproductive capacity or in 
inheritable genetic damage. Reduced reproductive capacity and inheritable genetic damage are 
toxicological endpoints which differ from carcinogenicity and therefore, the negative results for the 
carcinogenicity study cannot be used to overrule this concern. Also it is not clear if (and if so to what 
extent) the threshold mechanism mentioned above would be relevant for genotoxic effects in the 
germ cells. Therefore, the Panel concluded that presently these five substances cannot be evaluated 
through the Procedure. 
The Panel recognised that the studies which provided indications for germ cell genotoxicity are of 
limited validity. For that reason a robust GLP-controlled cytogenetic investigation in mouse 
spermatocytes according to the OECD Guideline 483 is requested. 
Additional data submitted by industry 
In response to the EFSA request in FGE.220 of a cytogenetic study in mouse spermatocytes (OECD TG 
483), Industry has submitted the following data: 
 2-Year carcinogenicity bioassay in rats with a substance coded ST 07 C99 (this is the study on 
[FL-no: 13.010] by Kelly & Bolte, 2003); 
 Oral male fertility study of FURANEOL = 4-Hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 
13.010] (test article code ST17C07) in rats (Sloter, 2008); 
 Oral micronucleus assay in bone marrow cells of the mouse with NEOFURANEOL (no 
identification of this substance is available) (Honarvar, 2008); 
 Mouse lymphoma (TK) specific locus mutation assay with compound 0478/1 (Ross and Harris, 
1979). 
Evaluation of additional data 
The Panel noted that among the studies submitted by Industry, only the rat fertility study, which 
includes also the analysis of dominant lethals, is considered relevant for the specific EFSA request. 
The 2-year carcinogenicity bioassay in rats by Kelly and Bolte (Kelly and Bolte, 2003) was already 
evaluated by the Panel in the previous version of FGE.220. It was considered as a valid, negative 
study, however not relevant for the evaluation of possibly inheritable damage. Also the mouse bone 
marrow micronucleus assay with neofuraneol (Honarvar, 2008) and the in vitro mouse lymphoma TK 
assay (Ross and Harris, 1979) are considered not relevant to clear the concern for possible inheritable 
damage. Furthermore, an adequate identification of the test substance Neofuraneol was not possible, 
due to incomplete reporting. For these reasons these three studies will not be further considered in 
this section. 
Oral Male Fertility Study of 4-Hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] in Rats (Sloter, 
2008) 
The objective of this study, performed according to ICH Guideline 4.1.1 (ICH, 1996) under GLP, was 
to determine the potential effects of 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] on 
mating, fertility and gonadal function in male rats with two separate mating trials. 4-Hydroxy-2,5-
dimethylfuran-3(2H)-one was administered by gavage once daily to three groups of 25 male 
Crl:CD(SD) rats. Dosage levels were 100, 500 and 1000 mg/kg bw per day. A concurrent control 
group of 25 males received the vehicle (propylene glycol) on a comparable regimen. The first mating 
(Phase I), following 2 weeks of male administration, using untreated females, was conducted to 
detect potential elicitation of early genotoxic effects on the embryo with reduced risk of test-article 
related deficiencies in mating or fertility. The second mating (Phase II), following 9 weeks of male 
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dose administration, was conducted following male exposure throughout a complete spermatogenic 
cycle using a second set of untreated females. 
There was no test-article related mortality noted in this study. A slightly lower mean body-weight gain 
was noted in the 1000 mg/kg per day group when evaluated for the overall treatment period. No test-
article related effects on male reproductive performance were observed at 100, 500 and 1000 mg/kg 
per day when males were mated with Phase I or Phase II females. In particular, there were no effects 
on spermatogenic endpoints (mean testicular and epididymal sperm numbers, sperm production rate, 
motility and morphology, reproductive organs or macroscopic findings) at any of the doses tested. The 
mean percentage of sperm with abnormal morphology (separated head and flagellum) was slightly 
higher in the 500 and 1000 mg/kg per day groups; however, this was primarily attributed to a single 
male in the respective groups and therefore not considered test-article related. The number of 
females mated and the number of pregnant females was comparable to controls. Uterine examination 
was performed for both Phase I and Phase II females. The analysis of embryonic data (corpora lutea, 
implantation sites, viable embryos, dead embryos, early resorptions, late resorptions, total 
resorptions, post- and pre-implantation losses) did not reveal dominant lethal effects. The study does 
not indicate a potential of 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] to affect male 
fertility. This study can be considered to be equivalent to an OECD 478 Dominant Lethal assay. The 
dominant lethal assay has been recommended as a follow-up study in case of positive results in the 
OECD TG 483 (Eastmond et al., 2009). On this basis the Panel considers it acceptable to substitute 
the requested study according to OECD Guideline 483 with the Dominant Lethal test. 
Conclusion on additional data 
The results of a valid rat fertility and dominant lethal study have shown that 4-hydroxy-2,5-
dimethylfuran-3(2H)-one is unable to induce both adverse effects on male rat reproductive capacity 
and dominant lethality. On this basis the Panel concludes that for this substance there is no concern 
for its potential to induce heritable genetic damage or adverse effects on male reproductive capacity. 
Accordingly the substances [FL-nos: 13.010, 13.084, 13.085, 13.099 and 13.176] can be evaluated 
using the Procedure. 
For a summary of in vitro / in vivo genotoxicity data considered by EFSA see Tables 2, 3 and 4. 
2.4.3. Genotoxicity studies and conclusion on genotoxicity - text taken7 from 
FGE.220Rev3 (EFSA CEF Panel, 2015). 
The following text is relevant for one substance [FL-no: 13.089] in this FGE. 
In FGE.220Rev3 a genotoxic potential for the flavouring substance [FL-no: 13.175] could be ruled out 
based on new data from an in vitro micronucleus study. As [FL-no: 13.175] is considered to be 
structurally related to a candidate substance in the present FGE.99Rev1, [FL-no: 13.089], the Panel 
concluded that a read-across could be applied for the genotoxicity data for [FL-no: 13.175] to also 
cover [FL-no: 13.089]. The structures of the two substances are shown in the table below. 
FL-no Chemical name Structural formula 
13.175 4-Acetyl-2,5-dimethylfuran-3(2H)-one 
 
13.089 2,5-Dimethyl-4-methoxyfuran-3(2H)-one 
 
In vitro micronucleus study for 4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] 
In response to the request to clarify the results of an in vitro micronucleus assay, the Industry has 
submitted a new study with 4-acetyl-2,5-dimethylfuran-3(2H)-one [Fl-no: 13.175]: ‘Induction of 
                                                          
7 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present FGE 
has been removed. In addition, minor editorial changes were included to maintain the logic of the text. 
O
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micronuclei in cultured human peripheral blood lymphocytes (Lloyd, 2014)’. This study is a follow-up 
of the in vitro micronucleus study (Lloyd, 2012) evaluated in FGE.220Rev2. In that study (Lloyd, 2012) 
the induction of micronuclei in human lymphocytes treated with [FL-no: 13.175] for 3+21 hours, in 
the presence of S9-mix, was considered by the Panel to be equivocal, therefore a repetition of the 
experiment was requested. The new study (Lloyd, 2014) was conducted to investigate the 
reproducibility of the findings under the test conditions of 3+21 hours in the presence of S9-mix. In 
the follow-up study, the frequency of micronuclei was assessed in cultured human peripheral blood 
lymphocytes (whole blood cultures pooled from two healthy male volunteers in a single experiment) 
following treatment with the same concentrations (1000, 1250 and 1542 μg/mL) of 4-acetyl-2,5-
dimethylfuran-3(2H)-one as before in the presence of a metabolising system (S9-mix) from livers of 
rats induced with Aroclor 1254. After 48 hours of culture initiation (stimulation by PHA), cultures were 
treated for 3 hours followed by 21 hours of recovery. The highest concentration was equal to the 
highest concentration used in the previous study and is equivalent to 10 mM, or the maximum 
required test concentration (MW = 154.2). Cyclophosphamide (CPA 3.0 μg/mL) was used as a 
clastogenic positive control chemical in the presence of rat liver S9-mix. Cytochalasin B (6 μg/ml) was 
added at the end of the 3-hour treatment in order to block cytokinesis and generate binucleate cells 
for analysis, and it remained in the cultures during the recovery period. In this follow-up study, unlike 
the findings of the previously reported study, a marginally significant increase (p ≤ 0.05) in the mean 
frequency of micronuclei was reported only at the lowest of the three concentrations of 4-acetyl-2,5-
dimethylfuran-3(2H)-one tested (1000 μg/mL) when compared to the concurrent vehicle control 
following scoring of 8000 cells (4000 cells per replicate). However, the MNBN frequencies of both 
replicate cultures (0.68 % and 0.5 %) at this concentration remained well within the normal historical 
control range (0.1 to 0.9 %). This finding shows that 4-acetyl-2,5- dimethylfuran-3(2H)-one did not 
induce reproducible and consistent increases of micronuclei frequency across replicate cultures in 
independent studies, indicating that the observed statistically significant increases in MNBN in the first 
study (Lloyd, 2012) are of no biological relevance. On this basis, 4-acetyl-2,5-dimethylfuran-3(2H)-one 
is considered negative for clastogenicity and aneugenicity in the in vitro micronucleus assay when 
tested up to a maximum concentration of 1542 μg/mL for 3 hours plus 21 hours recovery period in 
the presence of S9-mix. 
Conclusion on additional genotoxicity data – text taken from FGE.220rev3 (EFSA CEF 
Panel, 2015) 
4-Acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] did not induce mutations in the Ames test with 
and without metabolic activation (Bowen, 2011). There was an equivocal result observed in an in vitro 
micronucleus assay, however, in the follow up study (Lloyd, 2014) on 4-acetyl-2,5-dimethylfuran-
3(2H)-one did not induce reproducible statistically significant increase in MNBN cells across replicate 
cultures indicating that the test substance can be considered negative for clastogenicity and 
aneugenicity. The Panel therefore concluded that 4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 
13.175] does not give rise to concern with respect to genotoxicity and accordingly can be evaluated 
using the Procedure. These results are also applicable to two other substances: 2,5-dimethyl-4-
methoxyfuran-3(2H)-one [FL-no: 13.089] and 2,5-dimethyl-4-ethoxyfuran-3(2H)-one [FL-no: 13.117]. 
For a summary of in vitro / in vivo genotoxicity data considered by EFSA see Table 5. 
2.4.4. EFSA Considerations on genotoxicity 
Based on genotoxicity data provided for the structurally related 4-acetyl-2,5-dimethylfuran-3(2H)-one 
[FL-no: 13.175], the Panel concluded, that there is no concern with respect to genotoxicity for 2,5-
dimethyl-4-methoxyfuran-3(2H)-one [FL-no: 13.089] and accordingly this substance can be evaluated 
using the Procedure. 
The Panel concluded that the positive results observed in the genotoxicity studies on the substances 
[FL-nos: 13.010, 13.084, 13.085, 13.099 and 13.176] were due to the production of reactive oxygen 
species, potentiated by the presence of metals in the cell medium. The resulting DNA damage is only 
observed once the cell antioxidant capacity has been exhausted. This effect is unlikely to occur at the 
low levels used to flavour foods. A concern for a potential to elicit heritable genetic damage was 
alleviated by the results of a valid rat fertility and dominant lethal study which show that 4-hydroxy-
2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] is unable to induce both adverse effects on male rat 
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reproductive capacity and dominant lethality. On this basis the Panel concludes that for this substance 
and structurally related substances there is no concern for its potential to induce heritable genetic 
damage or adverse effects on male reproductive capacity. Accordingly, available genotoxicity data 
presented in this FGE do not preclude the evaluation of these substances [FL-nos: 13.010, 13.084, 
13.085, 13.099 and 13.176] using the Procedure. 
3. Assessment 
 Application of the Procedure to six furanone derivatives evaluated 3.1.
by the JECFA 
According to the JECFA five substances belong to structural class II and one substance [FL-no: 
13.176] to structural class III using the decision tree approach presented by Cramer et al. (Cramer et 
al., 1978). 
3.1.1. One substance from the 65th and 69th meetings of the JECFA (JECFA, 
2006b and d; 2009a and b) 
For substance [FL-no: 13.176] the JECFA concluded that the Procedure for the Safety Evaluation of 
Flavouring Agents could not be applied to this group because of the unresolved toxicological concerns 
related to the epoxidation and opening of the furan ring. 
3.1.2. Five substances from the 63rd meeting (JECFA, 2005b; 2006a) 
The JECFA concluded four [FL-nos: 13.084, 13.085, 13.089 and 13.099] of these five furanone 
derivatives at step A3 in the JECFA Procedure, i.e. the substances are expected to be metabolised to 
innocuous products (step 2) and the intakes for the substances are below the thresholds for their 
structural classes (step A3). 
The last substance [FL-no: 13.010] has intake above the threshold of concern for the corresponding 
structural class (step A3); it is not endogenous (step A4), but an adequate NOAEL of 200 mg/kg bw 
per day is available from the two year carcinogenicity study by Kelly and Bolte, 2003 (Kelly and Bolte, 
2003) that provides an adequate margin of safety (2.7 × 103) from the exposure as a flavouring 
substance (step A5). 
In conclusion, the JECFA evaluated the four substances to be of no safety concern at the estimated 
levels of intake as flavouring substances based on the MSDI approach. 
The evaluations of the furanone derivatives are summarised in Table 6. 
 EFSA Considerations on the assessment 3.2.
The Panel agrees only with the application of the Procedure as performed by the JECFA for one 
substance [FL-no: 13.010]. 
The JECFA stated that the four substances [FL-nos: 13.084, 13.085, 13.089 and 13.099] belong to 
structural class II, but according to TNO (TNO, 2014) the data on natural occurrence indicate that 
these substances cannot be considered to be common components of food as their occurrence has 
only been measured qualitatively in a few food categories or quantitatively in an amount less than  
5 ppm in only one food category. Therefore the Panel disagrees with the allocation of these 
substances to structural class II and allocates these four substances to structural class III. 
With regards to the substance [FL-no: 13.176], the Panel disagrees with the conclusions by the 
JECFA. The JECFA put the assessment of this structural class III substance on hold because of 
concerns for a potential for epoxidation and ring opening which may lead to genotoxic activity. The 
Panel regarded this substance to be sufficiently structurally related to the other substances in this 
group. In FGE.220Rev1, the Panel concluded that data available on substances structurally related to 
all the candidate substances in the present FGE demonstrate that these substances do not pose a 
concern for genotoxicity and can be evaluated through the Procedure. 
Flavouring Group Evaluation 99, Revision 1 
 
 
 
www.efsa.europa.eu/efsajournal 19 EFSA Journal 2015;13(11):4286 
 
Since the exposure estimates (MSDI) for Europe for three substances [FL-nos: 13.085, 13.089 and 
13.176] are below the threshold for structural class III (i.e. 90 μg/person per day), at step A3 of the 
Procedure it is concluded that these three substances do not pose a safety concern when used as a 
flavouring substance in food.  
For the remaining two substances [FL-nos: 13.084 and 13.099] the exposure estimates (MSDI) for 
Europe are above the threshold for structural class III. Since these substances are not endogenous 
their evaluation proceeds to step A5 of the Procedure. At this step the respective exposure estimates 
(160 and 400 μg/capita per day) can be compared to the NOAEL of 200 mg/kg bw per day for [FL-no 
13.010], which is available from the two year carcinogenicity study by Kelly and Bolte (Kelly and Bolte, 
2003). This NOAEL is based on decreases in mean body weights and body weight gains of male and 
female rats exposed to 400 mg 4-hydroxy-2,5-dimethyl-3(2H)-furanone/kg bw per day, compared to 
those of the controls in the last part of the study. No neoplasms or non-neoplastic lesions were 
attributed to exposure to 4-hydroxy-5-dimethyl-3(2H)-furanone. Adequate margins of safety of 7.5 × 
104 and 3.0 × 104 can be calculated for [FL no: 13.084] and [FL-no: 13.099], respectively, from which 
it is concluded that these two substances do not pose a safety concern when used as a flavouring 
substance in food. 
Thus the Panel concluded that there is no safety concern for any of the candidate substances in this 
FGE based on the MSDI approach. 
4. Conclusions 
The present revision of FGE.99, FGE.99Rev1, includes the assessment of one additional candidate 
substance, the 2,5-dimethyl-4-methoxyfuran-3(2H)-one [FL-no: 13.089], which was evaluated by the 
JECFA at its 63rd meeting. This substance, containing an α,β-unsaturated carbonyl, raised concern for 
genotoxicity. In the recently published FGE.220Rev3, new genotoxicity data on the structurally related 
4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] have become available. The Panel concluded 
that the data available rules out the concern for genotoxicity for [FL-no: 13.089] and accordingly this 
substance can be evaluated through the Procedure in this revision. 
This consideration deals with six flavouring substances [FL-nos: 13.010, 13.084, 13.085, 13.089, 
13.099 and 13.176], which belong to a group of 18 tetrahydrofuran and furanone derivatives and a 
group of 40 furan-substituted aliphatic hydrocarbons, alcohols, aldehydes, ketones, carboxylic acids 
and related esters, sulphides, disulphides and ethers evaluated by the JECFA at the 63rd, 65th and 
69th meetings.  
The Panel agrees with the application of the Procedure as performed by the JECFA for only one 
substance [FL-no: 13.010] considered in this FGE. The JECFA stated that the four substances [FL-nos: 
13.084, 13.085, 13.089 and 13.099] belong to structural class II, but as data on natural occurrence 
indicate that these substances cannot be considered to be common components of food, the Panel 
disagree with this and allocates these four substances to structural class III. In addition, for the 
substance [FL-no: 13.176] the JECFA concluded that the Procedure for the Safety Evaluation of 
Flavouring Agents could not be applied because of the unresolved toxicological concerns relating to 
the epoxidation and opening of the furan ring. The Panel disagreed with the conclusions by the JECFA 
and regarded this substance to be sufficiently structurally related to the other substances in this 
group. 
The Panel concluded that there is no safety concern for the six substances [FL-nos: 13.010, 13.084, 
13.085, 13.089, 13.099 and 13.176] in this FGE, based on the MSDI approach. 
In order to determine whether the conclusion for the six JECFA evaluated substances can be applied 
to the materials of commerce, it is necessary to consider the available specifications. Adequate 
specifications including complete purity criteria and identity tests and information on stereoisomeric 
composition are available for all JECFA evaluated substances considered in this FGE.  
For all six substances evaluated through the Procedure, use levels are required to calculate the 
mTAMDIs in order to identify those flavouring substances that need more refined exposure 
assessment and to finalise the evaluation. 
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bw body weight 
CAS Chemical Abstract Service 
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CoE Council of Europe 
DNA deoxyribonucleic acid 
EPA United States Environmental Protection Agency 
FAO Food and Agriculture Organization of the United Nations 
FEMA Flavor and Extract Manufacturers Association 
FGE Flavouring Group Evaluation 
FLAVIS (FL) Flavour Information System (database) 
GLP good laboratory practise 
I.p. intraperitoneal 
IR infrared spectroscopy 
JECFA The Joint FAO/WHO Expert Committee on Food Additives 
MSDI maximised survey-derived daily intake 
mTAMDI modified theoretical added maximum daily intake 
NCE normochromatic erythrocyte 
NOEL no observed effect level 
NOAEL no observed adverse effect level 
NTP national toxicology program 
OECD Organization for Economic Co-operation and Development 
PCE polychromatic erythrocyte 
(Q)SAR (quantitative) structure-activity relationship 
SCE sister chromatic exchange 
SCF Scientific Committee on Food 
WHO World Health Organization 
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Appendix A – Summary of genotoxicity and toxicity data 
Table 2:  Genotoxicity data (in vitro) evaluated by JECFA (JECFA, 2006a) and by EFSA in FGE.220Rev1 (EFSA CEF Panel, 2011) 
Chemical Name 
[FL-no]  
Test System Test Object  Concentration Reported 
Result  
Reference  Comments (e) 
4-Hydroxy-2,5-
dimethylfuran-3(2H)-
one [13.010] 
Reversed mutation S. typhimurium TA1535, 
TA1537, TA1538,TA100 and 
TA98 
10.0, 33.3, 100.0, 333.3, 
1000, 2000, 3300, 4000, 
6000, 8000 µg/plate 
Positive  
(a, b) 
(Gilroy et al., 
1978) 
 
Valid. Unpublished non-GLP study. 
The report contains sufficient 
details. Result is considered valid. 
Reversed mutation S. typhimurium TA100 and 
TA98 
0–10000 µg/plate Positive  
(a, b) 
(Hiramoto et al., 
1996b) 
 
Valid. Positive in TA100 (+/– S9); 
negative in TA98 (+/- S9). 
Reversed mutation S. typhimurium TA100, 
TA102, TA98 and TA97 
500–4000 µg/plate Positive  
(a, c) 
(Xing et al., 
1988) 
 
Limited validity. No methodological 
details, but stated to be performed 
according to (Maron and Ames, 
1983). Some errors reduce the 
trustworthiness of the paper. 
Reversed mutation E. coli WP2 uvrA- 10.0, 33.3, 100.0, 333.3, 
1000, 3300 µg/plate 
Negative (Gilroy et al., 
1978) 
 
Valid. Unpublished non-GLP study. 
The report contains sufficient 
details. Result is considered valid. 
DNA damage  B. subtilis H17 (Rec+) and 
M45 (Rec-) 
20, 40, 60, 80, 120 
µg/disc 
Positive (Xing et al., 
1988) 
 
Validity cannot be evaluated (Test 
system with low predictive value for 
genotoxicity).  No methodological 
details, but stated to be performed 
according to (Kada et al., 1972). 
DNA strand breaks  pBR322 DNA 2.6–780 µmol/l 
(0.3–100 mg/l) 
Positive (Hiramoto et al., 
1996b) 
 
Valid. Single strand breaks caused 
by redox cycling of the substance in 
combination with metal ions, 
generating reactive oxygen species. 
4-Hydroxy-5-
methylfuran-3(2H)-
one [13.085] 
Reversed mutation S. typhimurium TA100 and 
TA98 
0–5000 µg/plate Positive  
(a, b) 
(Hiramoto et al., 
1996a) 
 
Limited validity. Limited due to 
uncertainty of test substance. 
Positive in TA100 (+/- S9); negative 
in TA98 (+/- S9). 
DNA strand breaks  pBR322 DNA 0–900 µmol/l 
(0–103mg/l) 
Positive  
(a, d) 
(Hiramoto et al., 
1996a) 
 
Valid. Single strand breaks caused 
by redox cycling of the substance in 
combination with metal ions, 
generating reactive oxygen species. 
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Chemical Name 
[FL-no]  
Test System Test Object  Concentration Reported 
Result  
Reference  Comments (e) 
2,5-Dimethyl-3(2H)-
furanone [13.119] 
Reverse mutation S. typhimurium TA1535, 
TA1537, TA98,TA100 and 
TA102  
0–5000 µg/plate Negative (RCC - CCR, 
2007) 
 
Valid. According to current 
guidelines. 
2-Ethyl-4-hydroxy-5-
methyl-3(2H)-
furanone [13.084] 
Reversed mutation S. typhimurium TA100 and 
TA98 
0–10000 µg/plate Positive  
(a, b) 
(Li et al., 1998) 
 
Valid. Positive with and without S9 
in TA100; negative in TA98 (+/- 
S9). 
DNA strand breaks pBR322 DNA 0–2000 M Positive (d) (Li et al., 1998) 
 
Valid. Single strand breaks caused 
by redox cycling of the substance in 
combination with metal ions, 
generating reactive oxygen species. 
(a): With and without metabolic activation provided by S9 (9000 x g supernatant from rodent liver). 
(b): Positive results only observed in TA100. 
(c): Positive results in all strains at the highest dose tested. 
(d): Only positive without inhibitors of redox cycling and ROS scavengers. 
(e): Validity of genotoxicity studies: 
Valid. 
Limited validity (e.g. if certain aspects are not in accordance with OECD Guidelines or current standards and / or limited documentation). 
Insufficient validity (e.g. if main aspects are not in accordance with any recognised guidelines (e.g. OECD) or current standards and/or inappropriate test system). 
Validity cannot be evaluated (e.g. insufficient documentation, short abstract only, too little experimental details provided). 
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Table 3:  Genotoxicity data (in vivo) evaluated by JECFA (JECFA, 2006a) and by EFSA in FGE.220Rev1 (EFSA CEF Panel, 2011) 
Chemical Name 
[FL-no]  
Test System Test Object  Route Dose Reporte
d Result  
Reference  Comments (a) 
4-Hydroxy-2,5-
dimethylfuran-
3(2H)-one [13.010] 
Micronucleus 
formation 
Mouse, bone 
marrow 
Not stated 0, 186, 232 or 
309 mg/kg bw 
Positive (Xing et al., 1988) Limited validity. Important data not given. 
Reference to methodological description 
could not be traced. 
Chromosomal 
aberration 
Mouse 
spermatocytes 
Not stated 0, 232, 464 or 
928 mg/kg bw 
Positive (Xing et al., 1988) Limited validity. Important data not given. 
Reference to methodological description 
could not be traced. Predominant 
aberration; malsegregation of 
chromosomes. 
Sister 
chromatid 
exchange 
Mouse, bone 
marrow 
Intra-
abdominal 
injection 
0, 185, 232, 
303 mg/kg 
Positive (Xing et al., 1988) Validity cannot be assessed. Dose-related 
increase; statistically significant at all dose 
levels, but max increase < 2-fold. Effect not 
adequately specified; very intense exposure 
to BrdU.  Non-validated protocol. Relevance 
for the evaluation of genotoxicity 
questionable. 
Sister 
chromatid 
exchange 
Mouse 
spermatocytes 
Oral 
(gavage) 
200, 400 or 
800 mg/kg bw 
Positive (Tian et al., 1992) 
 
Limited validity. Relevance for the 
evaluation of genotoxicity questionable; 
non-validated test protocol. 
Micronucleus 
formation 
Mouse early 
sperm cells 
Oral 
(gavage) 
200, 400 or 
800 mg/kg bw 
Positive (Tian et al., 1992) 
 
Limited validity Non-validated test protocol. 
Micronucleus 
formation 
Mouse peripheral 
blood cells 
Gavage 1000, 2000 
3000 mg/kg  bw 
Positive (Hiramoto et al., 1998) 
 
Valid 
Micronucleus 
formation 
Male mice 
peripheral 
erythrocytes 
I.p. 500, 1000, 
1500 mg/kg 
bw 
Positive (Hiramoto et al., 
1996b) 
 
Valid 
2-Ethyl-4-hydroxy-
5-methyl-3(2H)-
furanone [13.084] 
Micronucleus 
formation 
Mouse peripheral 
blood cells 
Gavage 0, 1000, 2000 
and 3000 
mg/kg bw  
Positive (Hiramoto et al., 1998) 
 
Valid 
Micronucleus 
formation 
Male mice 
peripheral 
erythrocytes 
I.p. 0, 500, 1000 
and 1500 
mg/kg bw 
Positive (Li et al., 1998) 
 
Valid 
(a): Validity of genotoxicity studies: 
Valid. 
Limited validity (e.g. if certain aspects are not in accordance with OECD guidelines or current standards and / or limited documentation). 
Insufficient validity (e.g. if main aspects are not in accordance with any recognised guidelines (e.g. OECD) or current standards and/or inappropriate  test system). 
Validity cannot be evaluated (e.g. insufficient documentation, short abstract only, too little experimental details provided).  
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Table 4:  Additional genotoxicity data (in vitro and in vivo) evaluated by EFSA in FGE.220Rev1 (EFSA CEF Panel, 2011) 
Chemical Name 
[FL-no]  
Test System Test Object  Route Dose Reported Result  Reference  Comments (a) 
4-Hydroxy-2,5-
dimethylfuran-3(2H)-
one [13.010] 
Mouse Lymphoma L5178Ytk+/- 
mouse 
lymphoma cells 
- 111, 167, 250, 375 
and 750 µg/ml 
Negative both with 
and without S9 
(Ross and Harris, 
1979) 
Limited validity.  
Study not performed 
according to current 
guideline. Too short 
treatment and no 
differentiation between 
small and large colonies. 
Dominant lethal 
assay in a rat 
fertility study 
Dominant 
lethals in 
Crl:CD(SD) 
male rats 
(25/group) 
Oral 
gavage 
100, 500 and 1000 
mg/kg bw per day 
for 2 weeks (Phase 
I) and 9 weeks 
(Phase II) 
No increase of 
dominant lethal 
effects 
(Sloter, 2008) Valid GLP study in 
accordance with ICH 
Guideline 4.1.1. 
(a): Validity of genotoxicity studies: 
Valid. 
Limited validity (e.g. if certain aspects are not in accordance with OECD guidelines or current standards and / or limited documentation). 
Insufficient validity (e.g. if main aspects are not in accordance with any recognised guidelines (e.g. OECD) or current standards and/or inappropriate  test system). 
Validity cannot be evaluated (e.g. insufficient documentation, short abstract only, too little experimental details provided). 
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Table 5:  Additional genotoxicity data (in vitro) evaluated by EFSA in FGE.220Rev3 (EFSA CEF Panel, 2015) 
Chemical Name  
[FL-no]  
Test 
System 
Test Object  Dose Reported 
Result  
Reference  Comments  
2,5-Dimethylfuran-
3(2H)-one [13.119] 
Reverse 
Mutation 
S. typhimurium TA98, TA100, 
TA102, TA1535 and TA1537 
3–5000 μg/plate (a,b) Negative (Sokolowski, 
2007) 
 
All strains were negative. Study design 
complied with current GLP and OECD 
recommendations. Acceptable top 
concentration was achieved. 
S. typhimurium TA98, TA100, 
TA102, TA1535 and TA1537 
33–5000μg/plate (a,c) Negative 
Micronucleus 
Assay 
Human peripheral blood 
lymphocytes 
900–1120 μg/mL (a,f) 
900–1120 μg/mL (d,g) 
Negative (Lloyd, 2011) The MNBN cell frequencies in all treated 
cultures fell within the normal range. 
Complies with draft OECD Guideline 487 
and GLP recommendations. 
4-Acetyl-2,5-
dimethylfuran-3(2H)-
one [13.175] 
Reverse 
Mutation 
S. typhimurium TA98, TA100, 
TA102, TA1535 and TA1537 
0.32–5000 μg/plate (a,b) Negative (Bowen, 2011) Evidence of toxicity was observed at 
5000μg/plate in all strains in the absence 
and presence of S9. Study design complied 
with current GLP and OECD 
recommendations. 
78.13–5000 μg/plate (b,d) 
78.13–5000μg/plate (c,e) 
Negative 
Micronucleus 
Assay 
Human peripheral blood 
lymphocytes 
1000–1542 μg/mL (a,f)  
400–900 μg/mL (d,g) 
Equivocal (Lloyd, 2012) Study in compliance with GLP and OECD 
recommendations. Statistical significant 
increase, dose-related, in the presence of 
S9-mix at all three concentrations in a first 
experiment. Lower statistical significance at 
the two highest concentrations in an 
enlarged scoring, carried out with an 
unjustified approach. Mean MNBN cell 
frequencies fell within the historical control 
range with exception of a single replicate 
(see main text). 
1000, 1250 and 1542 
μg/mL (e,f)  
Negative (Lloyd, 2014)  
(a): With and without S9 metabolic activation. 
(b): Plate incorporation method. 
(c): Pre-incubation method. 
(d): Without S9 metabolic activation. 
(e): With S9 metabolic activation. 
(f): 3-hour incubation with 21-hour recovery period. 
(g): 24-hour incubation with no recovery period. 
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Appendix B – Summary of Safety Evaluations 
Table 6:  Summary of safety evaluation of furanone derivatives (JECFA, 2006a; 2009a) 
FL-no 
JECFA-
no 
EU Register name Structural formula EU MSDI (a)  
US MSDI 
(g/capita 
per day) 
 
Class (b) 
Evaluation 
procedure path (c) 
Outcome 
on the 
named 
compound  
(d) or (e) 
EFSA conclusion on the named 
compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
EFSA 
conclusion on 
the material of 
commerce 
13.084 
1449 
2-Ethyl-4-hydroxy-5-
methyl-3(2H)-furanone 
 
160 
13 
Class II 
A3: Intake below 
threshold 
d Evaluated in FGE.220Rev1, 
genotoxicity concern could be 
ruled out. EFSA allocated the 
substance to Class III.   
No safety concern at the 
estimated level of intake based on 
the MSDI approach. 
No safety 
concern at the 
estimated level 
of intake based 
on the MSDI 
approach. 
13.085 
1450 
4-Hydroxy-5-
methylfuran-3(2H)-one 
 
5.6 
0.07 
Class II 
A3: Intake below 
threshold 
d Evaluated in FGE.220Rev1, 
genotoxicity concern could be 
ruled out.  EFSA allocated the 
substance to Class III.   
No safety concern at the 
estimated level of intake based on 
the MSDI approach. 
No safety 
concern at the 
estimated level 
of intake based 
on the MSDI 
approach. 
13.089 
1451 
2,5-Dimethyl-4-
methoxyfuran-3(2H)-one 
 
19 
0.7 
Class II 
A3: Intake below 
threshold 
d Evaluated in FGE.220Rev3, 
genotoxicity concern could be 
ruled out. EFSA allocated the 
substance to Class III. 
No safety concern at the 
estimated level of intake based on 
the MSDI approach. 
No safety 
concern at the 
estimated level 
of intake based 
on the MSDI 
approach. 
13.099 
1456 
4-Acetoxy-2,5-
dimethylfuran-3(2H)-one 
 
400 
8 
Class II 
A3: Intake below 
threshold 
d Evaluated in FGE.220Rev1, 
genotoxicity concern could be 
ruled out.  EFSA allocated the 
substance to Class III.  No safety 
concern at the estimated level of 
intake based on the MSDI 
approach. 
No safety 
concern at the 
estimated level 
of intake based 
on the MSDI 
approach. 
O
OHO
O
OHO
O
O O
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FL-no 
JECFA-
no 
EU Register name Structural formula EU MSDI (a)  
US MSDI 
(g/capita 
per day) 
 
Class (b) 
Evaluation 
procedure path (c) 
Outcome 
on the 
named 
compound  
(d) or (e) 
EFSA conclusion on the named 
compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
EFSA 
conclusion on 
the material of 
commerce 
13.010 
1446 
4-Hydroxy-2,5-
dimethylfuran-3(2H)-one 
 
960 
5203 
Class II 
A3: Intake above 
threshold, A4: Not 
endogenous, A5: 
Adequate NOAEL 
exists 
d Evaluated in FGE.220Rev1, 
genotoxicity concern could be 
ruled out.  No safety concern at 
the estimated level of intake 
based on the MSDI approach. 
No safety 
concern at the 
estimated level 
of intake based 
on the MSDI 
approach. 
13.176 
1519 
Furaneyl butyrate  
 
12 
4 
Class III 
No evaluation 
 Evaluated in FGE.220Rev1, 
genotoxicity concern could be 
ruled out.  
No safety concern at the 
estimated level of intake based on 
the MSDI approach. 
No safety 
concern at the 
estimated level 
of intake based 
on the MSDI 
approach.  
Register name 
to be changed 
to 4-Butyroxy-
2,5-dimethyl-
3(2H)-furanone 
(EFFA, 2012). 
(a): EU MSDI: Amount added to food as flavour in (kg / year) × 10E9 / (0.1 × population in Europe (= 375 × 10E6) × 0.6 × 365) = µg/capita per day. 
(b): Thresholds of concern: Class I = 1800 µg/person per day, Class II = 540 µg/person per day, Class III = 90 µg/person per day. 
(c): Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
(d): No safety concern based on intake calculated by the MSDI approach of the named compound. 
(e): Data must be available on the substance or closely related substances to perform a safety evaluation. 
 
 
 
O
OHO
